Vir Biotechnology Competitors and Similar CompaniesClear all
Vir Biotechnology's competitors and similar companies include Kalaris Therapeutics.
 Vir Biotechnology Vir Biotechnology is a biopharmaceutical company that develops therapies for infectious diseases and cancer. |  Kalaris Therapeutics Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases. | |
Founding Date | Founding Date 2016 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ Bellinzona, CH | Locations Waltham, US HQ Dublin, IE Milan, IT |
Employees | Employees 40830% decrease | Employees 695% decrease |
Valuation ($) | Valuation ($) 1 b | Valuation ($) 103.1 m |
Financial | ||
Net income | Net income ($438m) (FY, 2025) | Net income ($43.4m) (FY, 2025) |
Operating ⚠ | ||
Patents (US) | Patents (US) 1 (Oct, 2019) | Patents (US) 2 (Jul, 2020) |
Funding | ||
Total funding raised | Total funding raised $ 637.7m | Total funding raised $ 159m |
For sources of this data, please see the company profile
View Company Profiles
Kalaris Therapeutics
HQ
Waltham, US
Employees
6
Kalaris Therapeutics (formerly known as AlloVir and ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases.
View company